MBX Biosciences
Valuation
$25.8M
Funding
$0
Founded
2019
MBX Biosciences revenue, team size, customer count, churn, and more in 2026.
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.
Last updated
MBX Biosciences Revenue
We do not have information about MBX Biosciences's revenue yet.
MBX Biosciences Valuation, Funding Rounds
MBX Biosciences's most recent disclosed valuation is $25.8M.
MBX Biosciences is a bootstrapped SaaS company, self-funded since its founding in 2019, with no outside investment to date.
| Year | Round | Amount | Valuation | % Sold |
|---|
MBX Biosciences Employees & Team Size
We do not have information about MBX Biosciences's team yet.
Customers
We do not have customer count information for MBX Biosciences yet.
Frequently Asked Questions about MBX Biosciences
What is MBX Biosciences's revenue?
GetLatka has not confirmed a public revenue figure for MBX Biosciences.
How much funding does MBX Biosciences have?
MBX Biosciences raised $0.
How many employees does MBX Biosciences have?
MBX Biosciences has 0 employees.
Where is MBX Biosciences headquarters?
MBX Biosciences is headquartered in Carmel, Indiana, United States.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .